Clinical studies of lactoferrin in children

Biochemistry and Cell Biology

Volumn 90, Issue 3, 2012, Pages 457-467

  Ochoa, Theresa J ^a,b   Pezo, Alonso ^a   Cruz, Karen ^a   Chea Woo, Elsa ^a   Cleary, Thomas G ^b  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Children; Clinical studies; Clinical trials; Lactoferrin

Indexed keywords

BREASTFEEDING; CHILD MORTALITY; CHILDREN; CLINICAL STUDY; CLINICAL TRIAL; CRITICAL REVIEW; IMMUNOMODULATION; IRON METABOLISM; LACTOFERRIN; LOW BIRTH WEIGHTS;

BIOCHEMISTRY; CELL CULTURE;

PEDIATRICS;

LACTOFERRIN; PLACEBO;

ANEMIA; BIRTH WEIGHT; CHILD CARE; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; FECES MICROFLORA; HUMAN; IMMUNOMODULATION; INTESTINE INFECTION; IRON METABOLISM; NEWBORN SEPSIS; NONHUMAN; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CHILD; CHILD HEALTH SERVICES; CLINICAL TRIALS AS TOPIC; COMMUNICABLE DISEASES; FECES; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOMODULATION; INFANT, NEWBORN; IRON METABOLISM DISORDERS; LACTOFERRIN; SEPSIS;

BOVINAE;

EID: 84861390197     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/o11-087     Document Type: Review

References (63)

1. Appelmelk B.J. An Y.Q. Thijs B.G. MacLaren D.M. de Graaff J. 1994. Recombinant human bactericidal/permeability-increasing protein (rBPI23) is a universal lipopolysaccharide-binding ligand. Infect. Immun. 62 (8): 3564-3567. 8039930
2. Artym J. Zimecki M. Paprocka M. Kruzel M.L. 2003. Orally administered lactoferrin restores humoral immune response in immunocompromised mice. Immunol. Lett. 89 (1): 9-15. 10.1016/S0165-2478(03)00102-0 12946859
3. Artym J. Zimecki M. Kruzel M.L. 2004. Effects of lactoferrin on IL-6 production by peritoneal and alveolar cells in cyclophosphamide-treated mice. J. Chemother. 16 (2): 187-192. 15216955
4. Artym J. Zimecki M. Kuryszko J. Kruzel M.L. 2005. Lactoferrin accelerates reconstitution of the humoral and cellular immune response during chemotherapy-induced immunosuppression and bone marrow transplant in mice. Stem Cells Dev. 14 (5): 548-555. 10.1089/scd.2005.14.548 16305339
5. Balmer S.E. Scott P.H. Wharton B.A. 1989. Diet and faecal flora in the newborn: lactoferrin. Arch. Dis. Child. 64 (12): 1685-1690. 10.1136/adc.64.12. 1685 2696433
6. Benjamin D.K. Jr Stoll B.J. 2006. Infection in late preterm infants. Clin. Perinatol. 33 (4): 871-882, abstract x. 10.1016/j.clp.2006.09.005 17148010
7. Berlutti F. Schippa S. Morea C. Sarli S. Perfetto B. Donnarumma G. Valenti P. 2006. Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strains. Biochem. Cell Biol. 84 (3): 351-357. 10.1139/o06-039 16936806
8. Black R.E. Cousens S. Johnson H.L. Lawn J.E. Rudan I. Bassani D.G. et al. Child Health Epidemiology Reference Group of WHO and UNICEF. 2010. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet, 375 (9730): 1969-1987. 10.1016/S0140-6736(10)60549-1 20466419
9. Borghesi A. Tzialla C. Decembrino L. Manzoni P. Stronati M. 2011. New possibilities of prevention of infection in the newborn. J. Matern. Fetal Neonatal Med. 24 (Suppl. 2): 28-30. 21749301
10. Brandenburg K. Jurgens G. Muller M. Fukuoka S. Koch M.H. 2001. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol. Chem. 382 (8): 1215-1225. 10.1515/BC.2001.152 11592403
11. Brock J.H. 2002. The physiology of lactoferrin. Biochem. Cell Biol. 80 (1): 1-6. 10.1139/o01-212 11908632
12. Chierici R. Sawatzki G. Tamisari L. Volpato S. Vigi V. 1992. Supplementation of an adapted formula with bovine lactoferrin. 2. Effects on serum iron, ferritin and zinc levels. Acta Paediatr. 81 (6-7): 475-479. 10.1111/j.1651-2227.1992.tb12277.x 1392356
13. Davidsson L. Kastenmayer P. Yuen M. Lönnerdal B. Hurrell R.F. 1994. Influence of lactoferrin on iron absorption from human milk in infants. Pediatr. Res. 35 (1): 117-124. 10.1203/00006450-199401000-00025 8134189
14. Edde L. Hipolito R.B. Hwang F.F. Headon D.R. Shalwitz R.A. Sherman M.P. 2001. Lactoferrin protects neonatal rats from gut-related systemic infection. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (5): G1140-G1150. 11668022
15. Egashira M. Takayanagi T. Moriuchi M. Moriuchi H. 2007. Does daily intake of bovine lactoferrin-containing products ameliorate rotaviral gastroenteritis? Acta Paediatr. 96 (8): 1242-1244. 10.1111/j.1651-2227.2007.00393.x 17655624
16. Fairweather-Tait S.J. Balmer S.E. Scott P.H. Minski M.J. 1987. Lactoferrin and iron absorption in newborn infants. Pediatr. Res. 22 (6): 651-654. 10.1203/00006450-198712000-00007 3431946
17. Faix R.G. 2010. Bovine lactoferrin appears to decrease the incidence of sepsis in very low-birth weight infants. J. Pediatr. 156 (5): 856. 10.1016/j.jpeds.2010.02.052 20385324
18. Farnaud S. Evans R.W. 2003. Lactoferrin- A multifunctional protein with antimicrobial properties. Mol. Immunol. 40 (7): 395-405. 10.1016/S0161-5890(03) 00152-4 14568385
19. Goldman A.S. 2007. The immune system in human milk and the developing infant. Breastfeed. Med. 2 (4): 195-204. 10.1089/bfm.2007.0024 18081456
20. Guillen C. McInnes I.B. Vaughan D. Speekenbrink A.B. Brock J.H. 2000. The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis. Arthritis Rheum. 43 (9): 2073-2080. 10.1002/1529-0131(200009)43:9<2073::AID-ANR19>3.0.CO;2-U 11014359
21. Hernell O. Lönnerdal B. 2002. Iron status of infants fed low-iron formula: no effect of added bovine lactoferrin or nucleotides. Am. J. Clin. Nutr. 76 (4): 858-864. 12324301
22. Howie P.W. Forsyth J.S. Ogston S.A. Clark A. Florey C.D. 1990. Protective effect of breast feeding against infection. BMJ, 300 (6716): 11-16. 10.1136/bmj.300.6716.11 2105113
23. Jones G. Steketee R.W. Black R.E. Bhutta Z.A. Morris S.S. Bellagio Child Survival Study Group. 2003. How many child deaths can we prevent this year? Lancet, 362 (9377): 65-71. 10.1016/S0140-6736(03)13811-1 12853204
24. Kaufman D.A. 2009. Lactoferrin supplementation to prevent nosocomial infections in preterm infants. JAMA, 302 (13): 1467-1468. 10.1001/jama.2009.1449 19809031
25. King J.C. Jr Cummings G.E. Guo N. Trivedi L. Readmond B.X. Keane V. et al. 2007. A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants. J. Pediatr. Gastroenterol. Nutr. 44 (2): 245-251. 10.1097/01.mpg.0000243435.54958.68 17255839
26. Kruzel M.L. Zimecki M. 2002. Lactoferrin and immunologic dissonance: clinical implications. Arch. Immunol. Ther. Exp. (Warsz.), 50 (6): 399-410. 12546066
27. Lawn J.E. Cousens S. Zupan J. Lancet Neonatal Survival Steering Team. 2005. 4 million neonatal deaths: when? Where? Why? Lancet, 365 (9462): 891-900. 10.1016/S0140-6736(05)71048-5 15752534
28. Lee W.J. Farmer J.L. Hilty M. Kim Y.B. 1998. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect. Immun. 66 (4): 1421-1426. 9529062
29. Lönnerdal B. Hernell O. 1994. Iron, zinc, copper and selenium status of breast-fed infants and infants fed trace element fortified milk-based infant formula. Acta Paediatr. 83 (4): 367-373. 10.1111/j.1651-2227.1994.tb18121.x 8025391
30. Lönnerdal B. Lien E.L. 2003. Nutritional and physiologic significance of alpha-lactalbumin in infants. Nutr. Rev. 61 (9): 295-305. 10.1301/nr.2003.sept.295-305 14552064
31. Lucas A. Morley R. Cole T.J. Gore S.M. 1994. A randomised multicentre study of human milk versus formula and later development in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 70 (2): F141-F146. 10.1136/fn.70.2.F141 8154907
32. Lucas A. Morley R. Cole T.J. 1998. Randomised trial of early diet in preterm babies and later intelligence quotient. BMJ, 317 (7171): 1481-1487. 10.1136/bmj.317.7171.1481 9831573
33. Manzoni P. Rinaldi M. Cattani S. Pugni L. Romeo M.G. Messner H. et al. Italian Task Force for the Study and Prevention of Neonatal Fungal Infections, Italian Society of Neonatology. 2009. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA, 302 (13): 1421-1428. 10.1001/jama.2009.1403 19809023
34. Manzoni P. Decembrino L. Stolfi I. Pugni L. Rinaldi M. Cattani S. et al. Italian Task Force for the Study and Prevention of Neonatal Fungal Infections Italian Society of Neonatology. 2010. Lactoferrin and prevention of late-onset sepsis in the pre-term neonates. Early Hum. Dev. 86 (1 Suppl. 1): 59-61. 10.1016/j.earlhumdev.2010.01.009 20138718
35. Manzoni P. Mostert M. Stronati M. 2011. Lactoferrin for prevention of neonatal infections. Curr. Opin. Infect. Dis. 24 (3): 177-182. 10.1097/QCO.0b013e32834592e6 21415742
36. Mohan P. Abrams S.A. 2009. Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst. Rev. (1): CD007138. 19160324
37. Moreau M.C. Duval-Iflah Y. Muller M.C. Raibaud P. Vial M. Gabilan J.C. Daniel N. 1983. [Effect of orally administered bovine lactoferrin and bovine IgG on the establishment of Escherichia coli in the digestive tract of gnotobiotic mice and human newborn infants]. Ann. Microbiol. (Paris), 134B (3): 429-441. 6372577
38. Mulder A.M. Connellan P.A. Oliver C.J. Morris C.A. Stevenson L.M. 2008. Bovine lactoferrin supplementation supports immune and antioxidant status in healthy human males. Nutr. Res. 28 (9): 583-589. 10.1016/j.nutres.2008.05.007 19083463
39. Ochoa T.J. Cleary T.G. 2009. Effect of lactoferrin on enteric pathogens. Biochimie, 91 (1): 30-34. 10.1016/j.biochi.2008.04.006 18472012
40. Ochoa T.J. Chea-Woo E. Campos M. Pecho I. Prada A. McMahon R.J. Cleary T.G. 2008. Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization. Clin. Infect. Dis. 46 (12): 1881-1883. 10.1086/588476 18462105
41. Otsuki K. Yakuwa K. Sawada M. Hasegawa A. Sasaki Y. Mitsukawa K. et al. 2005. Recombinant human lactoferrin has preventive effects on lipopolysaccharide-induced preterm delivery and production of inflammatory cytokines in mice. J. Perinat. Med. 33 (4): 320-323. 10.1515/JPM.2005.057 16207117
42. Pammi M. Abrams S.A. 2010. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. (5): CD007137. 21975765
43. Qazi S.A. Stoll B.J. 2009. Neonatal sepsis: a major global public health challenge. Pediatr. Infect. Dis. J. 28 (1 Suppl.): S1-S2. 10.1097/INF. 0b013e31819587a9 19106756
44. Roberts A.K. Chierici R. Sawatzki G. Hill M.J. Volpato S. Vigi V. 1992. Supplementation of an adapted formula with bovine lactoferrin: 1. Effect on the infant faecal flora. Acta Paediatr. 81 (2): 119-124. 10.1111/j.1651-2227.1992. tb12186.x 1515754
45. Schulz-Lell G. Dörner K. Oldigs H.D. Sievers E. Schaub J. 1991. Iron availability from an infant formula supplemented with bovine lactoferrin. Acta Paediatr. Scand. 80 (2): 155-158. 10.1111/j.1651-2227.1991.tb11826.x 2035305
46. Spik G. Brunet B. Mazurier-Dehaine C. Fontaine G. Montreuil J. 1982. Characterization and properties of the human and bovine lactotransferrins extracted from the faeces of newborn infants. Acta Paediatr. Scand. 71 (6): 979-985. 10.1111/j.1651-2227.1982.tb09560.x 6818832
47. Steijns J.M. van Hooijdonk A.C. 2000. Occurrence, structure, biochemical properties and technological characteristics of lactoferrin. Br. J. Nutr. 84 (Suppl. 1): S11-S17. 10.1017/S0007114500002191 11242441
48. Stephens B.E. Vohr B.R. 2009. Neurodevelopmental outcome of the premature infant. Pediatr. Clin. North Am. 56 (3): 631-646. 10.1016/j.pcl.2009.03.005 19501696
49. Tarnow-Mordi W. Isaacs D. Dutta S. 2010. Adjunctive immunologic interventions in neonatal sepsis. Clin. Perinatol. 37 (2): 481-499. 10.1016/j.clp.2009.12.002 20569818
50. Tomita M. Wakabayashi H. Yamauchi K. Teraguchi S. Hayasawa H. 2002. Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochem. Cell Biol. 80 (1): 109-112. 10.1139/o01-230 11908633
51. Trif M. Guillen C. Vaughan D.M. Telfer J.M. Brewer J.M. Roseanu A. Brock J.H. 2001. Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases. Exp. Biol. Med. (Maywood), 226 (6): 559-564. 11395926
52. Vohr B.R. Poindexter B.B. Dusick A.M. McKinley L.T. Wright L.L. Langer J.C. Poole W.K. NICHD Neonatal Research Network. 2006. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age. Pediatrics, 118 (1): e115-e123. 10.1542/peds.2005-2382 16818526
53. Vohr B.R. Poindexter B.B. Dusick A.M. McKinley L.T. Higgins R.D. Langer J.C. Poole W.K. National Institute of Child Health and Human Development National Research Network. 2007. Persistent beneficial effects of breast milk ingested in the neonatal intensive care unit on outcomes of extremely low birth weight infants at 30 months of age. Pediatrics, 120 (4): e953-e959. 10.1542/peds.2006-3227 17908750
54. Ward P.P. Uribe-Luna S. Conneely O.M. 2002. Lactoferrin and host defense. Biochem. Cell Biol. 80 (1): 95-102. 10.1139/o01-214 11908649
55. Wharton B.A. Balmer S.E. Scott P.H. 1994. Faecal flora in the newborn. Effect of lactoferrin and related nutrients. Adv. Exp. Med. Biol. 357: 91-98. 10.1007/978-1-4615-2548-6-9 7762449
56. Zagulski T. Lipinski P. Zagulska A. Broniek S. Jarzabek Z. 1989. Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br. J. Exp. Pathol. 70 (6): 697-704. 2690922
57. Zavaleta N. Figueroa D. Rivera J. Sánchez J. Alfaro S. Lönnerdal B. 2007. Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea. J. Pediatr. Gastroenterol. Nutr. 44 (2): 258-264. 10.1097/MPG.0b013e31802c41b7 17255841
58. Zhang G.H. Mann D.M. Tsai C.M. 1999. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect. Immun. 67 (3): 1353-1358. 10024582
59. Zimecki M. Właszczyk A. Wojciechowski R. Dawiskiba J. Kruzel M. 2001. Lactoferrin regulates the immune responses in post-surgical patients. Arch. Immunol. Ther. Exp. (Warsz.), 49 (4): 325-333. 11726036
60. Zimecki M. Artym J. Chodaczek G. Kocieba M. Kruzel M. 2005. Effects of lactoferrin on the immune response modified by the immobilization stress. Pharmacol. Rep. 57 (6): 811-817. 16382201
61. Zuccotti G.V. Salvini F. Riva E. Agostoni C. 2006. Oral lactoferrin in HIV-1 vertically infected children: an observational follow-up of plasma viral load and immune parameters. J. Int. Med. Res. 34 (1): 88-94. 16604828
62. Zuccotti G.V. Vigano A. Borelli M. Saresella M. Giacomet V. Clerici M. 2007. Modulation of innate and adaptive immunity by lactoferrin in human immunodeficiency virus (HIV)-infected, antiretroviral therapy-naäraquo;ve children. Int. J. Antimicrob. Agents, 29 (3): 353-355. 10.1016/j.ijantimicag. 2006.11.017 17276659
63. Zuccotti G.V. Trabattoni D. Morelli M. Borgonovo S. Schneider L. Clerici M. 2009. Immune modulation by lactoferrin and curcumin in children with recurrent respiratory infections. J. Biol. Regul. Homeost. Agents, 23 (2): 119-123. 19589293